New drug trial offers hope for Tough-to-Treat advanced cancers
NCT ID NCT06956690
Summary
This is the first study in people to test a new drug called HMBD-501 for advanced cancers that have a specific marker called HER3 and have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug can help shrink or control tumors in patients with cancers like melanoma, non-small cell lung cancer, and breast cancer. The trial will first test increasing doses in a small group, then expand to more patients at the chosen dose to see how well it works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGLa Jolla, California, 92093, United States
Contact Email: •••••@•••••
-
Research Site
RECRUITINGIndianapolis, Indiana, 46250, United States
Contact Email: •••••@•••••
-
Research Site
RECRUITINGFarmington Hills, Michigan, 48334, United States
Contact Email: •••••@•••••
-
Research Site
RECRUITINGDallas, Texas, 75230, United States
Contact Email: •••••@•••••
-
Research Site
RECRUITINGSan Antonio, Texas, 78229, United States
Contact Email: •••••@•••••
-
Research Site
WITHDRAWNCampbelltown, New South Wales, 2560, Australia
-
Research Site
WITHDRAWNMiranda, New South Wales, 2228, Australia
Conditions
Explore the condition pages connected to this study.